The Food and Drug Administration (FDA) on Sunday released a list of 51 contraceptives which will be re-certified as safe and non-abortifacient, paving the way for the implementation of one of the key measures of the Reproductive Health Law.

This effectively lifts the temporary restraining order issued by the Supreme Court in 2015, and allows the Health Department to distribute over 200,000 implants in their inventory before they expire in September next year.

“Per the FDA’s Resolutions dated 10 November 2017, the foregoing contraceptive products have been determined to be non-abortifacient,” the FDA said in its advisory.

Included in the list are implants like Implanon and Implanon NXT; injectables like Protec, intrauterine devices Mirena and Securit-T; and pills or oral contraceptives like Estrelle, Daphne, Yasmin, and Nordette, among others.